DK0420464T3 - 3-isoxazolonderivater, deres fremstilling af deres terapeutiske anvendelser - Google Patents

3-isoxazolonderivater, deres fremstilling af deres terapeutiske anvendelser

Info

Publication number
DK0420464T3
DK0420464T3 DK90310125.1T DK90310125T DK0420464T3 DK 0420464 T3 DK0420464 T3 DK 0420464T3 DK 90310125 T DK90310125 T DK 90310125T DK 0420464 T3 DK0420464 T3 DK 0420464T3
Authority
DK
Denmark
Prior art keywords
optionally substituted
alkyl
substituted phenyl
preparation
hydrogen
Prior art date
Application number
DK90310125.1T
Other languages
English (en)
Inventor
Mitsuo Nagano
Junichi Sakai
Nobuyoshi Iwata
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Application granted granted Critical
Publication of DK0420464T3 publication Critical patent/DK0420464T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/12Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK90310125.1T 1989-09-26 1990-09-17 3-isoxazolonderivater, deres fremstilling af deres terapeutiske anvendelser DK0420464T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24970089 1989-09-26
JP9697690 1990-04-12

Publications (1)

Publication Number Publication Date
DK0420464T3 true DK0420464T3 (da) 1994-11-07

Family

ID=26438116

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90310125.1T DK0420464T3 (da) 1989-09-26 1990-09-17 3-isoxazolonderivater, deres fremstilling af deres terapeutiske anvendelser

Country Status (8)

Country Link
EP (1) EP0420464B1 (da)
KR (1) KR910006251A (da)
AT (1) ATE108444T1 (da)
CA (1) CA2026177A1 (da)
DE (1) DE69010606T2 (da)
DK (1) DK0420464T3 (da)
ES (1) ES2060056T3 (da)
IE (1) IE69020B1 (da)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA879631B (en) * 1986-12-26 1989-08-30 Sankyo Co Centrally-acting muscle relaxants

Also Published As

Publication number Publication date
KR910006251A (ko) 1991-04-29
EP0420464A3 (en) 1991-07-17
EP0420464A2 (en) 1991-04-03
ES2060056T3 (es) 1994-11-16
EP0420464B1 (en) 1994-07-13
IE69020B1 (en) 1996-07-24
ATE108444T1 (de) 1994-07-15
DE69010606T2 (de) 1995-03-23
DE69010606D1 (de) 1994-08-18
CA2026177A1 (en) 1991-03-27
IE903445A1 (en) 1991-04-10

Similar Documents

Publication Publication Date Title
NO873071L (no) Fremgangsmaate for fremstilling av amid-derivater.
DE68914292D1 (de) Zusammensetzung zur Behandlung von ischämischen Störungen in Organen.
DK517588A (da) L-dopa-derivater eller syreadditionssalte deraf, deres fremstilling og anvendelse
DK0419397T3 (da) Substituerede urinsyreforbindelser, deres fremstilling og anvendelse
FI913613A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 3-aryyli-indoli- ja 3-aryyli-indatsolijohdannaisten valmistamiseksi
FR2800735B1 (fr) Nouvelles aralkyle-1,2-diamines possedant une activite calcimimetique et leur mode de preparation
DK26289D0 (da) Anvendelse af 1,4-disubstitueret piperidinyl til fremstilling af et farmaceutisk praeparat til behandling af insomnia
ATE79257T1 (de) Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
HUT65268A (en) Process for preparation of optically active 2-amino-1,2,3,4-tetrahydro-naphtaline derivatives
KR910004559A (ko) 중추 신경계에 작용하는 무스카린성 약제인 4-(n-치환 아미노)-2-부티닐-1-우레아 및 티오우레아와 그의 유도체
ES2038710T3 (es) Un procedimiento de preparacion de un derivado de benzoxazina y su utilizacion.
ES8601850A1 (es) Un procedimiento para preparar derivados de ciclobutano
ES2109216T3 (es) Un procedimiento para la preparacion de una composicion farmaceutica con actividad relajante muscular de accion central.
PT87005A (pt) Process for preparing n-phenethylaminoalkyl-benzamide anti-arrhythmic agents
DK0420464T3 (da) 3-isoxazolonderivater, deres fremstilling af deres terapeutiske anvendelser
DK1083178T3 (da) Tetrahydroquinazolin-2,4-dioner og terapeutiske anvendelser deraf
ES481207A1 (es) Un procedimiento para l preparacion de derivados de benzoci-cloheptapiridinas.
DE69327077D1 (de) Carbamoylpyrrolidon-Derivate zur Behandlung von Depressionen und cerebrovasculären Störungen
KR910700236A (ko) 치환된 3-아자비사이클로[3,1,1]헵탄, 이의 제조방법 및 이의 용도
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.